No Data
No Data
Express News | Pacira Biosciences Inc: Awarded New U.S. Patent Covering Exparel Composition; Provides Protection Into 2044
US Manufacturing Index Rises To 43, Highest Since 2020
Express News | Pacira Biosciences Inc - No Serious Treatment-Emergent Adverse Events Reported
Express News | Pacira Biosciences Inc - Phase 1 Trial Shows Safety and Efficacy of Pcrx-201
Express News | Pacira Announces 104-Week Safety and Efficacy Data Following Local Administration of Pcrx-201 for Moderate to Severe Osteoarthritis of the Knee
Pacira BioSciences Insider Lowered Holding By 85% During Last Year